Exact Mass: 287.0946238
Exact Mass Matches: 287.0946238
Found 500 metabolites which its exact mass value is equals to given mass value 287.0946238
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Rutaecarpine
Rutecarpine is a member of beta-carbolines. Rutaecarpine is a natural product found in Bouchardatia neurococca, Zanthoxylum dimorphophyllum, and other organisms with data available. Rutaecarpine belongs to the family of Pyridopyrimidines. These are compounds containing a pyridopyrimidine, which consists of a pyridine fused to a pyrimidine. D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents Rutaecarpine, an alkaloid of Evodia rutaecarpa, is an inhibitor of COX-2 with an IC50 value of 0.28 μM. Rutaecarpine, an alkaloid of Evodia rutaecarpa, is an inhibitor of COX-2 with an IC50 value of 0.28 μM.
Lycorine
Lycorine is an indolizidine alkaloid that is 3,12-didehydrogalanthan substituted by hydroxy groups at positions and 2 and a methylenedioxy group across positions 9 and 10. Isolated from Crinum asiaticum, it has been shown to exhibit antimalarial activity. It has a role as a protein synthesis inhibitor, an antimalarial, a plant metabolite and an anticoronaviral agent. It derives from a hydride of a galanthan. Lycorine is a natural product found in Sternbergia clusiana, Pancratium trianthum, and other organisms with data available. Lycorine is a toxic crystalline alkaloid found in various Amaryllidaceae species, such as the cultivated bush lily (Clivia miniata), surprise lilies (Lycoris), and daffodils (Narcissus). It may be highly poisonous, or even lethal, when ingested in certain quantities. Symptoms of lycorine toxicity are vomiting, diarrhea, and convulsions. Lycorine, definition at mercksource.com Regardless, it is sometimes used medicinally, a reason why some groups may harvest the very popular Clivia miniata. An indolizidine alkaloid that is 3,12-didehydrogalanthan substituted by hydroxy groups at positions and 2 and a methylenedioxy group across positions 9 and 10. Isolated from Crinum asiaticum, it has been shown to exhibit antimalarial activity. relative retention time with respect to 9-anthracene Carboxylic Acid is 0.144 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.136 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.138 CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 2316 INTERNAL_ID 2316; CONFIDENCE Reference Standard (Level 1) [Raw Data] CBA60_Lycorine_pos_30eV.txt [Raw Data] CBA60_Lycorine_pos_10eV.txt [Raw Data] CBA60_Lycorine_pos_50eV.txt [Raw Data] CBA60_Lycorine_pos_40eV.txt [Raw Data] CBA60_Lycorine_pos_20eV.txt Lycorine is a natural alkaloid extracted from the Amaryllidaceae plant. Lycorine is a potent and orally active SCAP inhibitor with a Kd value 15.24 nM. Lycorine downregulates the SCAP protein level without changing its transcription[2]. Lycorine is also a melanoma vasculogenic inhibitor[3]. Lycorine can be used for the study of prostate cancer and metabolic diseases[2]. Lycorine is a natural alkaloid extracted from the Amaryllidaceae plant. Lycorine is a potent and orally active SCAP inhibitor with a Kd value 15.24 nM. Lycorine downregulates the SCAP protein level without changing its transcription[2]. Lycorine is also a melanoma vasculogenic inhibitor[3]. Lycorine can be used for the study of prostate cancer and metabolic diseases[2]. Lycorine is a natural alkaloid extracted from the Amaryllidaceae plant. Lycorine is a potent and orally active SCAP inhibitor with a Kd value 15.24 nM. Lycorine downregulates the SCAP protein level without changing its transcription[2]. Lycorine is also a melanoma vasculogenic inhibitor[3]. Lycorine can be used for the study of prostate cancer and metabolic diseases[2].
Tenofovir
C9H14N5O4P (287.07833740000007)
Tenofovir is only found in individuals that have used or taken this drug. Tenofovir, marketed by Gilead Sciences under the trade name Viread®, belongs to a class of antiretroviral drugs known as nucleotide analogue reverse transcriptase inhibitors (nRTIs), which block reverse transcriptase, an enzyme crucial to viral production in HIV-infected people. [Wikipedia]Tenofovir inhibits the activity of HIV reverse transcriptase by competing with the natural substrate deoxyadenosine 5’-triphosphate and, after incorporation into DNA, by DNA chain termination. Specifically, the drugs are analogues of the naturally occurring deoxynucleotides needed to synthesize the viral DNA and they compete with the natural deoxynucleotides for incorporation into the growing viral DNA chain. However, unlike the natural deoxynucleotides substrates, NRTIs and NtRTIs (nucleoside/tide reverse transcriptase inhibitors) lack a 3-hydroxyl group on the deoxyribose moiety. As a result, following incorporation of an NRTI or an NtRTI, the next incoming deoxynucleotide cannot form the next 5-3 phosphodiester bond needed to extend the DNA chain. Thus, when an NRTI or NtRTI is incorporated, viral DNA synthesis is halted, a process known as chain termination. All NRTIs and NtRTIs are classified as competitive substrate inhibitors. C471 - Enzyme Inhibitor > C1589 - Reverse Transcriptase Inhibitor > C97452 - Nucleoside Reverse Transcriptase Inhibitor D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D018894 - Reverse Transcriptase Inhibitors D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D044966 - Anti-Retroviral Agents COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D004791 - Enzyme Inhibitors > D019384 - Nucleic Acid Synthesis Inhibitors C254 - Anti-Infective Agent > C281 - Antiviral Agent Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Tenofovir (GS 1278) is a nucleotide reverse transcriptase inhibitor to treat HIV and chronic Hepatitis B (HBV)[1].
Norlaudanosoline
C16H17NO4 (287.11575220000003)
Norlaudanosoline (CAS: 4747-99-3), also known as tetrahydropapaveroline, belongs to the class of organic compounds known as benzylisoquinolines. These are organic compounds containing an isoquinoline to which a benzyl group is attached. Norlaudanosoline is a very strong basic compound (based on its pKa). Norlaundanosoline is a key intermediate in the synthesis of the benzylisoquinoline alkaloids, providing the upper isoquinoline portion of the morphinan skeleton. It is involved in alkaloid biosynthesis and is synthesized by the enzyme (S)-norlaudanosoline synthase. Formerly believed to be a biosynthetic precursor of morphine in Papaver somniferum, now disproved
Cyanidin
[C15H11O6]+ (287.05556060000004)
Cyanidin, also known as cyanidin chloride (CAS: 528-58-5), belongs to the class of organic compounds known as 7-hydroxyflavonoids. These are flavonoids that bear one hydroxyl group at the C-7 position of the flavonoid skeleton. Thus, cyanidin is considered to be a flavonoid lipid molecule. Cyanidin is a very hydrophobic molecule, practically insoluble (in water), and relatively neutral. Cyanidin (and its glycosides) is the most commonly occurring of the anthocyanins, a widespread group of pigments responsible for the red-blue colour of many fruits and vegetables (PMID: 14711454). BioTransformer predicts that cyanidin is a product of cyanidin 3-glucoside metabolism via a glycoside-hydrolysis reaction occurring in human gut microbiota and catalyzed by the EC.3.2.1.X enzyme (PMID: 30612223). Widely distributed anthocyanidin, found especies in Vaccinium subspecies (blueberries, bilberries, whortleberries), cherries, raspberries, red onions, red wine and black tea. Cyanidin is found in many foods, some of which are papaya, hyacinth bean, sweet basil, and abalone.
NIFURTIMOX
P - Antiparasitic products, insecticides and repellents > P01 - Antiprotozoals > P01C - Agents against leishmaniasis and trypanosomiasis > P01CC - Nitrofuran derivatives D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent
(1S,2R)-1-C-(indol-3-yl)glycerol 3-phosphate
C11H14NO6P (287.05587140000006)
Indole-3-glycerol phosphate, also known as c1-(3-indolyl)-glycerol 3-phosphate, is a member of the class of compounds known as 3-alkylindoles. 3-alkylindoles are compounds containing an indole moiety that carries an alkyl chain at the 3-position. Indole-3-glycerol phosphate is slightly soluble (in water) and a moderately acidic compound (based on its pKa). Indole-3-glycerol phosphate can be found in a number of food items such as german camomile, lambsquarters, other soy product, and hazelnut, which makes indole-3-glycerol phosphate a potential biomarker for the consumption of these food products. Indole-3-glycerol phosphate may be a unique E.coli metabolite. D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents
Tetraphyllin B
Tetraphyllin B is found in papaya. Tetraphyllin B is isolated from dried damiana leaves (Turnera diffusa Isolated from dried damiana leaves (Turnera diffusa). Tetraphyllin B is found in papaya.
Sulmazole
C14H13N3O2S (287.07284380000004)
C78274 - Agent Affecting Cardiovascular System > C78322 - Cardiotonic Agent D004791 - Enzyme Inhibitors > D010726 - Phosphodiesterase Inhibitors D020011 - Protective Agents > D002316 - Cardiotonic Agents D002317 - Cardiovascular Agents
Gabazine
C15H17N3O3 (287.12698520000004)
D018377 - Neurotransmitter Agents > D018682 - GABA Agents > D018756 - GABA Antagonists
norlaudanosoline
C16H17NO4 (287.11575220000003)
Origin: Animal; SubCategory_DNP: Isoquinoline alkaloids, Benzylisoquinoline alkaloids relative retention time with respect to 9-anthracene Carboxylic Acid is 0.055 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.054 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.053 Acquisition and generation of the data is financially supported by the Max-Planck-Society IPB_RECORD: 2522; CONFIDENCE confident structure
Cycloguanil Hydrochloride
D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents D004791 - Enzyme Inhibitors > D005493 - Folic Acid Antagonists D007004 - Hypoglycemic Agents > D001645 - Biguanides
noroxymorphone
C16H17NO4 (287.11575220000003)
noroxymorphone is a metabolite of oxymorphone. Oxymorphone (Opana, Numorphan, Numorphone) or 14-Hydroxydihydromorphinone is a powerful semi-synthetic opioid analgesic first developed in Germany in 1914, patented in the USA by Endo Pharmaceuticals in 1955 and introduced to the United States market in January 1959 and other countries around the same time. It (along with hydromorphone) was designed to have less incidence of side effects than morphine and heroin. (Wikipedia) D002492 - Central Nervous System Depressants > D009294 - Narcotics > D053610 - Opiate Alkaloids C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist
Pipermethystine
C16H17NO4 (287.11575220000003)
Pipermethystine is found in beverages. Pipermethystine is an alkaloid from the leaves of kava (Piper methysticum). FDA advises against use of kava in food due to potential risk of severe liver damage (2002) Pipermethystine is an alkaloid present in the aerial (aboveground) portions of the kava plant. Alkaloid from the leaves of kava (Piper methysticum). FDA advises against use of kava in food due to potential risk of severe liver damage (2002)
Citrusinine II
Alkaloid from the root bark of Citrus sinensis variety brasiliensis (navel orange). Citrusinine II is found in sweet orange and citrus. Citrusinine II is found in citrus. Citrusinine II is an alkaloid from the root bark of Citrus sinensis var. brasiliensis (navel orange
Grandisine III
Grandisine III is found in citrus. Grandisine III is an alkaloid from roots of several hybrid seedlings resulting from a cross of Pummelo (Citrus grandis cv. May Pummelo x Marsh grapefruit (Citrus paradisi)) (Rutaceae). Alkaloid from roots of several hybrid seedlings resulting from a cross of Pummelo (Citrus grandis cv. May Pummelo x Marsh grapefruit (Citrus paradisi)) (Rutaceae). Grandisine III is found in citrus.
N-Ribosylhistidine
N tau-ribosylhistidine (His-R) is a histidine derivative found in the urine of histidinemic patients (histidinemia is an autosomal recessive metabolic disorder characterized by increased levels of histidine in blood, urine, and cerebrospinal fluid). The enzymes responsible for the formation of His-R are NAD (P) + nucleosidase [EC 3.2.2.5], nucleotide pyrophosphatase [EC 3.5.1.9] and 5-nucleotidase [EC 3.1.3.5]. (PMID: 2992472) [HMDB] N tau-ribosylhistidine (His-R) is a histidine derivative found in the urine of histidinemic patients (histidinemia is an autosomal recessive metabolic disorder characterized by increased levels of histidine in blood, urine, and cerebrospinal fluid). The enzymes responsible for the formation of His-R are NAD (P) + nucleosidase [EC 3.2.2.5], nucleotide pyrophosphatase [EC 3.5.1.9] and 5-nucleotidase [EC 3.1.3.5] (PMID: 2992472).
Clitocine
Nucleoside isolated from the mushroom Clitocybe inversa (edibility unknown). Clitocine is found in mushrooms. Clitocine is found in mushrooms. Nucleoside isolated from the mushroom Clitocybe inversa (edibility unknown Clitocine, an adenosine nucleoside analog isolated from mushroom, is a potent and efficacious readthrough agent. Clitocine acts as a suppressor of nonsense mutations and can induce the production of p53 protein in cells harboring p53 nonsense-mutated alleles. Clitocine can induce apoptosis in multidrug-resistant human cancer cells by targeting Mcl-1. Anticancer activity[1][2]. Clitocine, an adenosine nucleoside analog isolated from mushroom, is a potent and efficacious readthrough agent. Clitocine acts as a suppressor of nonsense mutations and can induce the production of p53 protein in cells harboring p53 nonsense-mutated alleles. Clitocine can induce apoptosis in multidrug-resistant human cancer cells by targeting Mcl-1. Anticancer activity[1][2].
Tricetanidin
C15H11O6+ (287.05556060000004)
Tricetanidin is found in tea. Tricetanidin is isolated from black tea (Thea sinensis). Isolated from black tea (Thea sinensis). Tricetanidin is found in tea. Tricetinidin is an intense red-colored chemical compound belonging to the 3-deoxyanthocyanidins. It can be found in black tea infusions.[1] Tricetinidin, in tea, would be a product of the oxidative degallation of epigallocatechin gallate (EGCG). 1-Benzopyrylium, 5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-, chloride (1:1). CAS Common Chemistry. CAS, a division of the American Chemical Society, n.d. https://commonchemistry.cas.org/detail?cas_rn=65618-21-5 (retrieved 2024-09-19) (CAS RN: 65618-21-5). Licensed under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0).
(2E)-Hexenedioylcarnitine
C13H21NO6 (287.13688060000004)
(2E)-Hexenedioylcarnitine is an acylcarnitine. More specifically, it is an (2E)-hexenedioic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. (2E)-Hexenedioylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine (2E)-Hexenedioylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].
(2E)-3-Methylpent-2-enedioylcarnitine
C13H21NO6 (287.13688060000004)
(2E)-3-methylpent-2-enedioylcarnitine is an acylcarnitine. More specifically, it is an (2E)-3-methylpent-2-enedioic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. (2E)-3-methylpent-2-enedioylcarnitine is therefore classified as a short chain AC. As a short-chain acylcarnitine (2E)-3-methylpent-2-enedioylcarnitine is a member of the most abundant group of carnitines in the body, comprising more than 50\\% of all acylcarnitines quantified in tissues and biofluids (PMID: 31920980). Some short-chain carnitines have been studied as supplements or treatments for a number of diseases, including neurological disorders and inborn errors of metabolism. In particular (2E)-3-methylpent-2-enedioylcarnitine is elevated in the blood or plasma of individuals with 3-hydroxy-3-methylglutarylCoA lyase deficiency (PMID: 32685354). (2E)-3-methylpent-2-enedioylcarnitine is elevated in the urine of individuals with 3-methylglutaconic aciduria (PMID: 7850987). Carnitine acetyltransferase (CrAT, EC:2.3.1.7) is responsible for the synthesis of all short-chain and short branched-chain acylcarnitines (PMID: 23485643). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].
Hex-3-enedioylcarnitine
C13H21NO6 (287.13688060000004)
hex-3-enedioylcarnitine is an acylcarnitine. More specifically, it is an hex-3-enedioic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. hex-3-enedioylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine hex-3-enedioylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].
(E)-3-(4-Chlorophenyl)-N-(4-methoxyphenyl)prop-2-enamide
1-[Amino-(3,4-dichloroanilino)methylidene]-2-propan-2-ylguanidine
D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent D007004 - Hypoglycemic Agents > D001645 - Biguanides
6-Chloro-2',3'-dideoxyguanosine
9-(2-Phosphonomethoxypropyl)adenine
C9H14N5O4P (287.07833740000007)
D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D018894 - Reverse Transcriptase Inhibitors D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D044966 - Anti-Retroviral Agents D004791 - Enzyme Inhibitors > D019384 - Nucleic Acid Synthesis Inhibitors
Incadronic acid
C78281 - Agent Affecting Musculoskeletal System > C67439 - Bone Resorption Inhibitor D050071 - Bone Density Conservation Agents > D004164 - Diphosphonates
Isomazole
C14H13N3O2S (287.07284380000004)
C78274 - Agent Affecting Cardiovascular System > C78322 - Cardiotonic Agent D004791 - Enzyme Inhibitors > D010726 - Phosphodiesterase Inhibitors D020011 - Protective Agents > D002316 - Cardiotonic Agents D002317 - Cardiovascular Agents
lycorine
C16H17NO4 (287.11575220000003)
N-(3-Methyl-1,1-dioxo-1,4-thiazinan-4-yl)-1-(5-nitro-2-furanyl)methanimine
Riparin III
C16H17NO4 (287.11575220000003)
7-Chloro-3-methyl-1-phenyl-1,2,4,5-tetrahydro-3-benzazepin-8-ol
1-hydroxy-3,6-dimethoxy-1,2-dimethyl-9H-carbazol-4-one
C16H17NO4 (287.11575220000003)
Tricetinidin
1-Benzopyrylium, 5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-, chloride (1:1). CAS Common Chemistry. CAS, a division of the American Chemical Society, n.d. https://commonchemistry.cas.org/detail?cas_rn=65618-21-5 (retrieved 2024-09-19) (CAS RN: 65618-21-5). Licensed under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0).
[1-(Phenylsulfonyl)-1H-indol-2-yl]methanol
C15H13NO3S (287.06161080000004)
Benzoic acid, 4-hydroxy-2-((2-hydroxybenzoyl)amino)-, methyl ester
2-acetamido-3,6-anhydro-2-deoxy-5-O-isovaleryl-D-glucofuranose|furanodictine A
C13H21NO6 (287.13688060000004)
10-Decarbamoyloxy-9-dehydroporfiromycin
C15H17N3O3 (287.12698520000004)
Michigazone
A member of the class phenoxazines that is 3H-phenoxazine substituted by methoxy, oxo, methoxy and hydroxymethyl groups at positions 2, 3, 4 and 8, respectively. It is a red pigment produced by the soil bacterium Streptomyces michiganensis.
Parvine
Parvine is a natural product found in Nauclea orientalis and Sarcocephalus latifolius with data available.
beta-D-glucopyranos-1-yl N-methylpyrrole-2-carboxylate
(S)-2-(3,4-dihydroxybenzoylamino)-3-phenylpropanol|nigerrimin A
C16H17NO4 (287.11575220000003)
6,7-dihydro-5H-indolo[3,2:3,4]pyrido[2,1-b]quinazolin-9-one|Pseudorutaecarpin|rutaecarpine
5-[(alpha-D-galactopyranosyloxy)methyl]-1H-pyrrole-2-carbaldehyde
6-[(alpha-D-galactopyranosyloxy)methyl]-3-pyridinol
3-Isopentenyl-4-methoxy-7,8-methylendioxy-2-chinolon|6-methoxy-7-(3-methyl-but-2-enyl)-9H-[1,3]dioxolo[4,5-h]quinolin-8-one|6-methoxy-7-(3-methylbut-2-enyl)-1,3-dioxolo<4,5-h>quinolin-8-one
C16H17NO4 (287.11575220000003)
3-(4-chlorophenyl)-N-(3-methoxyphenyl)-2-propenamide
Tenofovir
C9H14N5O4P (287.07833740000007)
C471 - Enzyme Inhibitor > C1589 - Reverse Transcriptase Inhibitor > C97452 - Nucleoside Reverse Transcriptase Inhibitor D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D018894 - Reverse Transcriptase Inhibitors D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D044966 - Anti-Retroviral Agents COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D004791 - Enzyme Inhibitors > D019384 - Nucleic Acid Synthesis Inhibitors C254 - Anti-Infective Agent > C281 - Antiviral Agent Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS CONFIDENCE standard compound; EAWAG_UCHEM_ID 3105 Tenofovir (GS 1278) is a nucleotide reverse transcriptase inhibitor to treat HIV and chronic Hepatitis B (HBV)[1].
Rutaecarpine
Rutaecarpine, an alkaloid of Evodia rutaecarpa, is an inhibitor of COX-2 with an IC50 value of 0.28 μM. Rutaecarpine, an alkaloid of Evodia rutaecarpa, is an inhibitor of COX-2 with an IC50 value of 0.28 μM.
C16H17NO4_6,11-Methano-6H-benzo[b]-1,3-benzodioxolo[5,6-e]azepine-8,9-diol, 5,6a,7,8,9,11-hexahydro
C16H17NO4 (287.11575220000003)
noroxymorphone
C16H17NO4 (287.11575220000003)
D002492 - Central Nervous System Depressants > D009294 - Narcotics > D053610 - Opiate Alkaloids C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist
Barterin
Pipermethystine
C16H17NO4 (287.11575220000003)
Clitocine
Clitocine, an adenosine nucleoside analog isolated from mushroom, is a potent and efficacious readthrough agent. Clitocine acts as a suppressor of nonsense mutations and can induce the production of p53 protein in cells harboring p53 nonsense-mutated alleles. Clitocine can induce apoptosis in multidrug-resistant human cancer cells by targeting Mcl-1. Anticancer activity[1][2]. Clitocine, an adenosine nucleoside analog isolated from mushroom, is a potent and efficacious readthrough agent. Clitocine acts as a suppressor of nonsense mutations and can induce the production of p53 protein in cells harboring p53 nonsense-mutated alleles. Clitocine can induce apoptosis in multidrug-resistant human cancer cells by targeting Mcl-1. Anticancer activity[1][2].
Tricetanidin
C15H11O6+ (287.05556060000004)
D020011 - Protective Agents > D000975 - Antioxidants
CAR 6:2;O2
C13H21NO6 (287.13688060000004)
Tricetinidin
C15H11O6+ (287.05556060000004)
D020011 - Protective Agents > D000975 - Antioxidants
N4-Acetyl-2-Fluoro-2-deoxycytidine
C11H14FN3O5 (287.09174459999997)
Benzamide, N-[(4-hydroxyphenyl)methyl]-3,4-dimethoxy
C16H17NO4 (287.11575220000003)
4-(CYANOMETHYL)PHENYL 4-METHYLBENZENE-1-SULFONATE
C15H13NO3S (287.06161080000004)
AMINO-(4-BENZYLOXY-3-METHOXY-PHENYL)-ACETIC ACID
C16H17NO4 (287.11575220000003)
(2S)-4,4-dimethyl-2-phenyl-1-oxa-4-azoniacyclohexan-2-ol
Methyl 4-(1-aminocyclopropyl)benzoate methanesulfonate (1:1)
C12H17NO5S (287.08273920000005)
Methyl 4-acetoxy-6-(dimethylamino)-2-naphthoate
C16H17NO4 (287.11575220000003)
2-Amino-N-(pyridin-3-ylmethyl)-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxamide
[1-(PHENYLSULFONYL)-1H-INDOL-3-YL]METHANOL
C15H13NO3S (287.06161080000004)
3-Pyrrolidinecarboxylic acid, 5-oxo-1-[[4-(trifluoromethyl)phenyl]methyl]-
diethyl 6-methylquinoline-2,3-dicarboxylate
C16H17NO4 (287.11575220000003)
Methyl 4-hydroxy-6-(4-morpholinyl)-2-naphthoate
C16H17NO4 (287.11575220000003)
2-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-_4-(trifluoromethyl)_benzenamine
C13H17BF3NO2 (287.13043680000004)
2-[4-methyl-2-[4-(trifluoromethyl)phenyl]-1,3-thiazol-5-yl]ethanol
C13H12F3NOS (287.05916579999996)
3-AZIDO-3-DEOXY-1,2:5,6-DI-O-ISOPROPYLIDENE-α-D-GLUCOFURANOSE
4-(5-Chloro-1-isopropyl-1H-pyrrolo[2,3-c]pyridin-3-yl)pyrimidin-2-amine
5-Morpholin-4-ylmethyl-2-phenyl-furan-3-carboxylicacid
C16H17NO4 (287.11575220000003)
2,3-NAPHTHALENEDIOL, 6-(DIMETHYLAMINO)-5,6,7,8-TETRAHYDRO-, HYDROBROMIDE
1-[(4-fluorophenyl)methylamino]cyclohexane-1-carboxylic acid,hydrochloride
1-(4-trifluoromethyl-benzyl)-piperidine-4-carboxylic acid hydrochloride
2-(Methylsulfonyl)-2,6-dihydropyrrolo[3,4-c]pyrazole-5(4H)-carboxylic acid tert-butyl ester
N-BENZYL-3-CARBOMETHOXY-4-PIPERIDONE, SODIUM SALT MONOHYDRATE, TECH.
Thionin acetate
C14H13N3O2S (287.07284380000004)
D000890 - Anti-Infective Agents > D023181 - Antimicrobial Cationic Peptides
2-(7-FLUORO-2-(4-FLUOROPHENYL)-1H-INDOL-3-YL)ACETIC ACID
(2S,4R)-1-(TERT-BUTOXYCARBONYL)-4-(2-METHOXY-2-OXOETHYL)PYRROLIDINE-2-CARBOXYLIC ACID
C13H21NO6 (287.13688060000004)
4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3-(trifluoromethyl)aniline
C13H17BF3NO2 (287.13043680000004)
Carbamimidothioic acid,N-cyano-N-[2-[[(4-methyl-1H-imidazol-5-yl)methyl]thio]ethyl]-, methyl ester
[2-(4-Methoxy-phenyl)-ethyl]-(4-methylsulfanyl-benzyl)-amine
Isoquinoline, 1,2,3,4-tetrahydro-2- (p-tolylsulfonyl)-
2-chloro-7-methyl-3-(5-propyl-1,2,4-oxadiazol-3-yl)quinoline
2-chloro-8-methyl-3-(5-propyl-1,2,4-oxadiazol-3-yl)quinoline
2-chloro-6-methyl-3-(5-propyl-1,2,4-oxadiazol-3-yl)quinoline
2-Phenylthiazole-5-boronic acid pinacol ester
C15H18BNO2S (287.11512380000005)
2-CHLORO-4,5,7,8-TETRAHYDRO-6H-THIENO[2,3-D]AZEPINE-6-CARBOXYLIC ACID, T-BUTYLESTER
C13H18ClNO2S (287.07467180000003)
ethyl 6-fluoro-4-(trifluoromethyl)quinoline-2-carboxylate
D-threo-beta-Methylsulfonylphenylserine ethyl ester
C12H17NO5S (287.08273920000005)
2-chloro-3-(5-isopropyl-1,2,4-oxadiazol-3-yl)-6-methylquinoline
(3-((2-Isopropyl-1H-imidazol-1-yl)methyl)phenyl)amine dihydrochloride
C13H19Cl2N3 (287.09559540000004)
7,7-dimethyl-3-(thiophen-2-ylmethyl)-6,8-dihydro-1H-quinoline-2,5-dione
5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-(2,2,2-trifluoroethyl)pyridine
C13H17BF3NO2 (287.13043680000004)
2-nitro-N-(2-nitrophenyl)benzamide
C13H9N3O5 (287.05421839999997)
4-aminophenyl-1-thio-beta-d-galactopyranoside
C12H17NO5S (287.08273920000005)
ETHYL 7-METHYL-2-(2-THIENYL)PYRAZOLO[1,5-A]PYRIMIDINE-6-CARBOXYLATE
C14H13N3O2S (287.07284380000004)
8-METHYL-QUINOLINE-2,3-DICARBOXYLIC ACID DIETHYL ESTER
C16H17NO4 (287.11575220000003)
5-(4-(ACETYLAMINO)PHENYL)-1H-IMIDAZOLE-2-ACETIC ACID ETHYL ESTER
C15H17N3O3 (287.12698520000004)
3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-5-(trifluoromethyl)aniline
C13H17BF3NO2 (287.13043680000004)
(3R,4R)-1-[(tert-butoxy)carbonyl]-4-(ethoxycarbonyl)pyrrolidine-
C13H21NO6 (287.13688060000004)
1-[4-(5-Nitro-1H-indol-3-yl)-1-piperidinyl]ethanone
C15H17N3O3 (287.12698520000004)
Methyl 6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline-3-carboxylate
5-METHOXY-N-(2-(THIOPHEN-2-YL)ETHYL)-1,2,3,4-TETRAHYDRONAPHTHALEN-2-AMINE
3-(METHOXYCARBONYL)-1-(2-ETHOXYETHYL)-4-NITRO-1H-PYRAZOLE-5-CARBOXYLIC ACID
C10H13N3O7 (287.07534680000003)
2-Amino-6-benzyl-4,5,6,7-tetrahydro-thieno[2,3-c]pyridine-3-carboxylic acid amide
ethyl 2-(2-ethoxy-2-oxoethyl)quinoline-3-carboxylate
C16H17NO4 (287.11575220000003)
2-(BENZOYLAMINO)-5,6-DIHYDRO-4H-CYCLOPENTA[B]THIOPHENE-3-CARBOXYLIC ACID
C15H13NO3S (287.06161080000004)
3-((tert-Butoxycarbonyl)amino)-2-naphthoic acid
C16H17NO4 (287.11575220000003)
3-amino-N,N-diethyl-4-(2-hydroxyethylamino)benzenesulfonamide
C12H21N3O3S (287.13035560000003)
3,6-Acridinediamine,N6,N6,2-trimethyl-, hydrochloride (1:1)
1-(4-METHYL-2-(4-(TRIFLUOROMETHYL)PHENYL)THIAZOL-5-YL)ETHANOL
C13H12F3NOS (287.05916579999996)
1H-Benz[de]isoquinoline-1,3(2H)-dione,2-(phenylmethyl)-
2-nitro-N-(4-nitrophenyl)benzamide
C13H9N3O5 (287.05421839999997)
(3-(N-(tert-butyl)sulfamoyl)-4-Methoxyphenyl)boronic acid
3-ETHOXY-2-(2-NAPHTHYLSULFONYL)ACRYLONITRILE
C15H13NO3S (287.06161080000004)
3-METHOXY-1-(PHENYLSULFONYL)-1H-INDOLE
C15H13NO3S (287.06161080000004)
4-Aminophenyl b-D-thiomannopyranoside
C12H17NO5S (287.08273920000005)
1-(4-(4-Amino-2-(trifluoromethyl)phenyl)piperazin-1-yl)ethanone
3-(4-(methylsulfonyl)phenyl)serine ethyl ester
C12H17NO5S (287.08273920000005)
TRANS-1-(tert-butoxycarbonyl)-4-(ethoxycarbonyl)pyrrolidine-3-carboxylic acid
C13H21NO6 (287.13688060000004)
2-(4-(ETHYLAMINO)PHENYL)-1,1,1,3,3,3-HEXAFLUOROPROPAN-2-OL
1-Benzyl-4-thiophen-2-yl-pyrrolidine-3-carboxylic acid
2-chloro-1-(3-phenyl-2,3-dihydro-1,4-benzoxazin-4-yl)ethanone
1-[(3-fluorophenyl)methylamino]cyclohexane-1-carboxylic acid
Methyl 2-amino-4-methoxy-5-(phenylmethoxy)benzoate
C16H17NO4 (287.11575220000003)
1-(4-CHLOROPHENYL)-3-(4-FLUOROPHENYL)-1H-PYRAZOL-5-AMINE
6-methoxy-1-(phenylsulfonyl)-1H-indole
C15H13NO3S (287.06161080000004)
Methyl 2-amino-4-benzyloxy-5-methoxybenzoate
C16H17NO4 (287.11575220000003)
besipirdine
C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist
(2Z)-3-(Acetylamino)-4-(2,4,5-trifluorophenyl)-2-butenoic acid methyl ester
2,6-dichloro-3-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine
C12H16BCl2NO2 (287.06510860000003)
2-[4-(3-FORMYL-2,5-DIMETHYL-1H-1-PYRROLYL)PHENOXY]PROPANOIC ACID
C16H17NO4 (287.11575220000003)
N-(2-Chloropyrimidin-4-yl)-N-methyl-2,3-dimethyl-2H-indazol-6-amine
N-ACETYL-N-(2-ISOPROPYL-4-OXO-3(4H)-QUI&
C15H17N3O3 (287.12698520000004)
P-AMINOPHENYL-1-THIO-β-D-GLUCOPYRANOS IDE
C12H17NO5S (287.08273920000005)
9-ACETYL-7-METHYL-2-MORPHOLINO-4H-PYRIDO[1,2-A]PYRIMIDIN-4-ONE
C15H17N3O3 (287.12698520000004)
1-[2-Hydroxy-3-nitro-5-(phenylmethoxy)phenyl]ethanone
4-(2-morpholin-4-ylethoxy)benzoic acid,hydrochloride
5-(4-chlorophenyl)-N-cyclopentyl-2-methylpyrimidin-4-amine
6-(2-CHLOROPHENYL)-4,4-DIMETHYL-1H-BENZO[D][1,3]OXAZIN-2(4H)-ONE
6-(3-CHLOROPHENYL)-4,4-DIMETHYL-1H-BENZO[D][1,3]OXAZIN-2(4H)-ONE
4-Ethyl-5-(5-phenyl-tetrazol-2-ylmethyl)-4H-[1,2,4]triazole-3-thiol
C12H13N7S (287.09530980000005)
trolamine salicylate
C13H21NO6 (287.13688060000004)
D000893 - Anti-Inflammatory Agents > D000894 - Anti-Inflammatory Agents, Non-Steroidal > D012459 - Salicylates C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic
methyl 2-[(2-chloroacetyl)amino]-4,5-dimethoxybenzoate
4-C-azido-2-deoxy-2-fluoro-beta-D-arabinouridine
C9H10FN5O5 (287.06659420000005)
N-(3,5-Dimethoxyphenyl)-4-methoxybenzamide
C16H17NO4 (287.11575220000003)
4-C-azido-3-deoxy-3-fluoro-Uridine
C9H10FN5O5 (287.06659420000005)
1-[4-(4-AMINO-2-TRIFLUOROMETHYLPHENYL)PIPERAZIN-1-YL]ETHANONE
Gonyautoxin IV
From Gonyaulax and Protogonyaulax subspecies Gonyautoxin IV is found in mollusks.
4-methoxy-3-(n,n-diethylsulfamoyl)phenylboronic acid
1-(1,3-dimethylpyrazol-4-yl)sulfonylpiperidine-4-carboxylic acid
3-PHENYL-2-(4,4,4-TRIFLUORO-3-OXO-BUT-1-ENYLAMINO)-PROPIONIC ACID
(4S)-(-)-T-BUTYLDIMETHYLSILOXY-2-CYCLOPENTEN-1-ONE
C16H17NO4 (287.11575220000003)
CP 93129 dihydrochloride
CP 93129 dihydrochloride is a potent 5HT1B receptor agonist. CP 93129 dihydrochloride has the potential for parkinson's disease research[1].
1-(benzenesulfonyl)-7-methoxyindole
C15H13NO3S (287.06161080000004)
6-(4-CHLOROPHENYL)-4,4-DIMETHYL-1H-BENZO[D][1,3]OXAZIN-2(4H)-ONE
3-(6-(trifluoromethyl)pyrazolo[1,5-a]pyridin-2-yl)benzonitrile
2-[(2,5-DIMETHOXY-4-NITROPHENYL)THIO]ETHANOHYDRAZIDE
4-benzyl-3-(thiophen-3-ylmethyl)-1H-1,2,4-triazole-5-thione
C14H13N3S2 (287.05508580000003)
3-(3-(3,4-Dichlorophenyl)piperidin-3-yl)propan-1-ol
C14H19Cl2NO (287.08436240000003)
7-Chloro-3-methyl-1-phenyl-1,2,4,5-tetrahydro-3-benzazepin-8-ol
2,6-Dihydroxy-N-(2-(4-methoxyphenyl)ethyl)benzamide
C16H17NO4 (287.11575220000003)
(R)-2,3,4,5-Tetrahydro-8-chloro-3-methyl-5-phenyl-1H-3-benzazepin-7-ol
2H-Indol-2-one, 1,3-dihydro-5-(3-pyridinyl)-3-(1H-pyrrol-2-ylmethylene)-
2,5-dimethyl-N-[(E)-(2-nitrophenyl)methylideneamino]furan-3-carboxamide
1H-Pyrrole-1-acetic acid, 3-(ethoxycarbonyl)-2-methyl-5-phenyl-
C16H17NO4 (287.11575220000003)
2-(4-Fluorophenyl)-2-oxoethyl 2-(methylamino)benzoate
3-(4-chlorophenyl)-5-propyl-1H-pyrazolo[1,5-a]pyrimidin-7-one
N-(3,4-dimethoxyphenyl)-4-methoxybenzamide
C16H17NO4 (287.11575220000003)
4-Diazoniophenylphosphorylcholine
C11H18N3O4P+2 (287.10348780000004)
N-(3-methoxyphenyl)-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxamide
2-(4-methoxyphenoxy)-N-(2-methoxyphenyl)acetamide
C16H17NO4 (287.11575220000003)
3-(4-Chlorophenyl)-1-(4-fluorophenyl)-1H-pyrazol-5-amine
4-(5-(1,3-Benzodioxol-5-yl)-1-oxo-2,4-pentadienyl)morpholine
C16H17NO4 (287.11575220000003)
(4S)-4-(2-Naphthylmethyl)-D-glutamic acid
C16H17NO4 (287.11575220000003)
(3,4,5-Trihydroxy-6-hydroxymethyl-tetrahydro-pyran-2-YL)-phosphoramidic acid dimethyl ester
Incadronic
C78281 - Agent Affecting Musculoskeletal System > C67439 - Bone Resorption Inhibitor D050071 - Bone Density Conservation Agents > D004164 - Diphosphonates
Naringenin dibenzoylmethane tautomer
C15H11O6- (287.05556060000004)
2,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-3H-chromen-5-olate
C15H11O6- (287.05556060000004)
3-(2,4-Dihydroxyphenyl)-7-hydroxy-4-oxo-2,3-dihydrochromen-5-olate
C15H11O6- (287.05556060000004)
2-(2-Carboxy-6-hydroxy-4-methylbenzoyl)-3-hydroxyphenolate
C15H11O6- (287.05556060000004)
(E)-3-(4-Chlorophenyl)-N-(4-methoxyphenyl)prop-2-enamide
2-amino-6-chloro-9-[5-(hydroxymethyl)oxolan-2-yl]-3H-purin-6-ol
D009676 - Noxae > D000963 - Antimetabolites > D015224 - Dideoxynucleosides
(2E)-3-Methylpent-2-enedioylcarnitine
C13H21NO6 (287.13688060000004)
N-(2,6-dimethoxy-4-pyrimidinyl)-3-phenylpropanamide
C15H17N3O3 (287.12698520000004)
(+)-Dihydrokaempferol 7-oxoanion
C15H11O6- (287.05556060000004)
Conjugate base of (+)-dihydrokaempferol.
2-methoxy-N-(4-methylphenyl)-4-(methylthio)benzamide
N-[5-[(2,2-dimethyl-1-oxopropyl)amino]-2-pyridinyl]-2-furancarboxamide
C15H17N3O3 (287.12698520000004)
2-(2-methylphenoxy)-N-[2-(methylthio)phenyl]acetamide
N-(2,3-dihydro-1,4-benzodioxin-3-ylmethyl)-5-ethyl-2-furancarboxamide
C16H17NO4 (287.11575220000003)
4-(2-methylphenyl)-3-(5-methyl-3-thiophenyl)-1H-1,2,4-triazole-5-thione
C14H13N3S2 (287.05508580000003)
2-(2-furanyl)-6,7,8,9-tetrahydro-5H-cyclohepta[2,3]thieno[2,4-b][1,3]oxazin-4-one
C15H13NO3S (287.06161080000004)
(17S,18S)-5,7-Dioxa-12-azapentacyclo[10.6.1.02,10.04,8.015,19]nonadeca-2,4(8),9,15-tetraene-17,18-diol
C16H17NO4 (287.11575220000003)
(2-oxooxolan-3-yl) (E)-2-cyano-3-(4-methoxyphenyl)prop-2-enoate
2-Hydroxy-2,3-dihydrogenistein-7-olate
C15H11O6- (287.05556060000004)
2-benzylidene-6-methyl-2,3,4,9-tetrahydro-1H-carbazol-1-one
2-[(3-Butan-2-yl-4-oxo-2-quinazolinyl)thio]propanenitrile
5-(2,3-dihydro-1H-indol-1-ylmethylene)-1-methyl-2-thioxodihydro-4,6(1H,5H)-pyrimidinedione
C14H13N3O2S (287.07284380000004)
2-(4-Chlorophenyl)-5-(1-piperidinyl)-4-oxazolecarbonitrile
2-[3-(3,4-Dihydroxyphenyl)prop-2-enoyl]-3,5-dihydroxyphenolate
C15H11O6- (287.05556060000004)
6-[(4-Chloroanilino)methylidene]-3-prop-2-enoxy-1-cyclohexa-2,4-dienone
5-(1,3-dioxoisoindol-2-yl)-1H-indole-3-carbonitrile
6-acetyl-6-amino-3-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1H-pyrimidin-2-one
(4S)-4,5,7-trihydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-3-olate
C15H11O6- (287.05556060000004)
Asp-Gly-Pro
A tripeptide composed of L-aspartic acid, glycine, and L-proline units joined in sequence.
[4-(2-Pyridinylmethyl)-1-piperazinyl]-thiophen-2-ylmethanone
8,8-dimethyl-2,9-dioxo-10H-pyrano[2,3-f][1]benzopyran-10-carboxaldehyde oxime
(2R)-2-[(2S,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyacetamide
C10H13N3O7 (287.07534680000003)
N-butyl-1,6-dihydro-5-(4-hydroxyphenyl)-6-oxo-2-pyrazinecarboxamide
C15H17N3O3 (287.12698520000004)
2-(2,5-Dimethoxyphenyl)-4-methyl-1,6-dihydroimidazo[4,5-d]pyridazin-3-ium-7-one
2-[(4,4-Dimethyl-2,6-dioxocyclohexyl)methylideneamino]benzoic acid
C16H17NO4 (287.11575220000003)
5-amino-1-(3-fluoro-4-morpholinophenyl)-1H-imidazole-4-carbonitrile
4-Ethoxycarbonylmethyl-3-methyl-1-para-tolyl-3-pyrroline-2,5-dione
C16H17NO4 (287.11575220000003)
1-Methyl-3-methoxycarbonyl-5-trimethylsilyl-2-phenylpyrrole
6,11-Phenylimino-5,6-dihydropyrrolo(1,2-C)(1,3)benzodiazepin-5-one
2,4-Diethyl-4,4A-dihydro-1H-(1,3,5)triazino(1,2-A)quinoline-1,3,6(2H,5H)-trione
C15H17N3O3 (287.12698520000004)
Gabazine
C15H17N3O3 (287.12698520000004)
D018377 - Neurotransmitter Agents > D018682 - GABA Agents > D018756 - GABA Antagonists
Indole-3-glycerol phosphate
C11H14NO6P (287.05587140000006)
D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents The (1S,2R)-diastereomer of 1-C-(indol-3-yl)glycerol 3-phosphate.
Volkenin
A cyanogenic glycoside that is (4R)-4-hydroxycyclopent-2-ene-1-carbonitrile attached to a beta-D-glucopyranosyloxy at position 1.
chlorproguanil
D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent D007004 - Hypoglycemic Agents > D001645 - Biguanides
sulmazole
C14H13N3O2S (287.07284380000004)
C78274 - Agent Affecting Cardiovascular System > C78322 - Cardiotonic Agent D004791 - Enzyme Inhibitors > D010726 - Phosphodiesterase Inhibitors D020011 - Protective Agents > D002316 - Cardiotonic Agents D002317 - Cardiovascular Agents
Isomazole
C14H13N3O2S (287.07284380000004)
C78274 - Agent Affecting Cardiovascular System > C78322 - Cardiotonic Agent D004791 - Enzyme Inhibitors > D010726 - Phosphodiesterase Inhibitors D020011 - Protective Agents > D002316 - Cardiotonic Agents D002317 - Cardiovascular Agents
1-C-(Indol-3-yl)glycerol 3-phosphate
C11H14NO6P (287.05587140000006)
D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents
Cyanidin cation
An anthocyanidin cation that is flavylium substituted at positions 3, 3, 4, 5 and 7 by hydroxy groups. 2-(3,4-Dihydroxyphenyl)-3,5,7-trihydroxy-1-benzopyrylium. CAS Common Chemistry. CAS, a division of the American Chemical Society, n.d. https://commonchemistry.cas.org/detail?cas_rn=13306-05-3 (retrieved 2024-09-27) (CAS RN: 13306-05-3). Licensed under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0).
tenofovir (anhydrous)
C9H14N5O4P (287.07833740000007)
A member of the class of phosphonic acids that is methylphosphonic acid in which one of the methyl hydrogens is replaced by a [(2R)-1-(6-amino-9H-purin-9-yl)propan-2-yl]oxy group. An inhibitor of HIV-1 reverse transcriptase, the bis(isopropyloxycarbonyloxymethyl) ester (disoproxil ester) prodrug is used as the fumaric acid salt in combination therapy for the treatment of HIV infection.
cytosylglucuronic acid
C10H13N3O7 (287.07534680000003)
An N-glycosyl compound that is cytosine in which the proton at position 1 is replaced by a beta-D-glucuronosyl residue.
O-[(2E)-hexenedioyl]carnitine
C13H21NO6 (287.13688060000004)
An O-acylcarnitine having (2E)-hexenedioyl as the acyl substituent.
4-hydroxy-3-(1-{[2-(4-hydroxyphenyl)ethyl]imino}ethyl)-6-methylpyran-2-one
C16H17NO4 (287.11575220000003)
(3r)-6-oxo-1-(3-phenylpropanoyl)-2,3-dihydropyridin-3-yl acetate
C16H17NO4 (287.11575220000003)
(1r,4s)-4-hydroxy-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}cyclopent-2-ene-1-carbonitrile
8-hydroxy-7-methoxy-2,2,6-trimethylpyrano[3,2-c]quinolin-5-one
C16H17NO4 (287.11575220000003)
(1s,17s,18s,19r)-5,7-dioxa-12-azapentacyclo[10.6.1.0²,¹⁰.0⁴,⁸.0¹⁵,¹⁹]nonadeca-2,4(8),9,15-tetraene-17,18-diol
C16H17NO4 (287.11575220000003)
2-{[hydroxy(2-hydroxyphenyl)methylidene]amino}-4-methoxybenzoic acid
(2e)-3-(4-hydroxy-3-methoxyphenyl)-n-[2-(3h-imidazol-4-yl)ethyl]prop-2-enimidic acid
C15H17N3O3 (287.12698520000004)
7-hydroxy-8-methoxy-2-methyl-5h-chromeno[4,3-b]pyridine-10-carboxylic acid
(1s,7s,16r)-16-methoxy-5-oxa-10-azatetracyclo[8.7.0.0¹,¹³.0²,⁷]heptadeca-2,12,14-triene-4,11-dione
C16H17NO4 (287.11575220000003)
1-[(2e)-3-(3,4-dimethoxyphenyl)prop-2-enoyl]-5,6-dihydropyridin-2-one
C16H17NO4 (287.11575220000003)
(3z)-3-(1-{[2-(4-hydroxyphenyl)ethyl]amino}ethylidene)-6-methylpyran-2,4-dione
C16H17NO4 (287.11575220000003)
5,7,20,21-tetraoxa-14-azahexacyclo[16.2.1.0²,¹⁰.0⁴,⁸.0¹¹,¹⁵.0¹¹,¹⁹]henicosa-2(10),3,8-triene
C16H17NO4 (287.11575220000003)
n-[1-(4-methoxy-6-oxopyran-2-yl)-2-phenylethyl]ethanimidic acid
C16H17NO4 (287.11575220000003)
(1r,13s,15s,18r)-5,7-dioxa-12-azapentacyclo[10.6.1.0²,¹⁰.0⁴,⁸.0¹³,¹⁸]nonadeca-2,4(8),9,16-tetraene-15,18-diol
C16H17NO4 (287.11575220000003)
n-{2-hydroxy-6-[(3-methylbutanoyl)oxy]-hexahydrofuro[3,2-b]furan-3-yl}ethanimidic acid
C13H21NO6 (287.13688060000004)
(1s,7r,16r)-16-methoxy-5-oxa-10-azatetracyclo[8.7.0.0¹,¹³.0²,⁷]heptadeca-2,12,14-triene-4,11-dione
C16H17NO4 (287.11575220000003)
16-methoxy-5-oxa-10-azatetracyclo[8.7.0.0¹,¹³.0²,⁷]heptadeca-2(7),12,14-triene-4,9-dione
C16H17NO4 (287.11575220000003)
16-methoxy-5-oxa-10-azatetracyclo[8.7.0.0¹,¹³.0²,⁷]heptadeca-2,12,14-triene-4,11-dione
C16H17NO4 (287.11575220000003)
5,7-dioxa-12-azapentacyclo[10.5.2.0¹,¹³.0²,¹⁰.0⁴,⁸]nonadeca-2,4(8),9,16-tetraene-15,18-diol
C16H17NO4 (287.11575220000003)
(2s,3r)-2,3-dihydroxy-3-(1h-indol-3-yl)propoxyphosphonic acid
C11H14NO6P (287.05587140000006)
(2s)-2-{[(2s)-2-amino-1-hydroxypropylidene]amino}-3-hydroxy-3-[(3r)-7-oxo-4-oxa-1-azabicyclo[3.2.0]heptan-3-yl]propanoic acid
(1s,16r)-16-methoxy-5-oxa-10-azatetracyclo[8.7.0.0¹,¹³.0²,⁷]heptadeca-2(7),12,14-triene-4,11-dione
C16H17NO4 (287.11575220000003)
16-methoxy-5-oxa-10-azatetracyclo[8.7.0.0¹,¹³.0²,⁷]heptadeca-2,12,14-triene-4,9-dione
C16H17NO4 (287.11575220000003)
(2s,3s,4s,5r,6r)-3,4,5-trihydroxy-6-(2-hydroxy-4-iminopyrimidin-1-yl)oxane-2-carboxylic acid
C10H13N3O7 (287.07534680000003)
(1r,13s,15r,18s)-5,7-dioxa-12-azapentacyclo[10.5.2.0¹,¹³.0²,¹⁰.0⁴,⁸]nonadeca-2,4(8),9,16-tetraene-15,18-diol
C16H17NO4 (287.11575220000003)
(+)-11-hydroxyvittatine
C16H17NO4 (287.11575220000003)
{"Ingredient_id": "HBIN000458","Ingredient_name": "(+)-11-hydroxyvittatine","Alias": "NA","Ingredient_formula": "C16H17NO4","Ingredient_Smile": "C1C(C=CC23C1N(CC2O)CC4=CC5=C(C=C34)OCO5)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "10825","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
2-benzamidobenzoic acid; 2',4-dihydroxy,me ester
{"Ingredient_id": "HBIN005344","Ingredient_name": "2-benzamidobenzoic acid; 2',4-dihydroxy,me ester","Alias": "NA","Ingredient_formula": "C15H13NO5","Ingredient_Smile": "NA","Ingredient_weight": "287.27","OB_score": "NA","CAS_id": "93289-91-9","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "8693","PubChem_id": "NA","DrugBank_id": "NA"}
2-benzamidobenzoic acid; 2'-hydroxy,4-methoxy
{"Ingredient_id": "HBIN005346","Ingredient_name": "2-benzamidobenzoic acid; 2'-hydroxy,4-methoxy","Alias": "NA","Ingredient_formula": "C15H13NO5","Ingredient_Smile": "NA","Ingredient_weight": "287.27","OB_score": "NA","CAS_id": "93289-90-8","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "8691","PubChem_id": "NA","DrugBank_id": "NA"}
amino[3,4-dihydroxy-5-(4-hydroxy-2-oxopyrimidin-1-yl)oxolan-2-yl]acetic acid
C10H13N3O7 (287.07534680000003)
(4as,7s)-6,7-dihydroxy-2-(4-hydroxyphenyl)-5-methoxy-4a,7-dihydro-1λ⁴-chromen-1-ylium
5,7,17-trioxa-12-azahexacyclo[10.6.2.0¹,¹³.0²,¹⁰.0⁴,⁸.0¹⁶,¹⁸]icosa-2,4(8),9-trien-15-ol
C16H17NO4 (287.11575220000003)
4-ethenylphenyl 3-amino-4-hydroxy-2-sulfanylbenzoate
C15H13NO3S (287.06161080000004)
(1s,13r,15r,16s,18r)-5,7,17-trioxa-12-azahexacyclo[10.6.2.0¹,¹³.0²,¹⁰.0⁴,⁸.0¹⁶,¹⁸]icosa-2,4(8),9-trien-15-ol
C16H17NO4 (287.11575220000003)
(1r,4s)-4-hydroxy-1-{[(2s,3r,4s,5s,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}cyclopent-2-ene-1-carbonitrile
(1s,17s,18r,19r)-5,7-dioxa-12-azapentacyclo[10.6.1.0²,¹⁰.0⁴,⁸.0¹⁵,¹⁹]nonadeca-2,4(8),9,15-tetraene-17,18-diol
C16H17NO4 (287.11575220000003)
(1s,17r,18s,19s)-5,7-dioxa-12-azapentacyclo[10.6.1.0²,¹⁰.0⁴,⁸.0¹⁵,¹⁹]nonadeca-2,4(8),9,15-tetraene-17,18-diol
C16H17NO4 (287.11575220000003)
(1s,11r,15r)-5,7-dioxa-12-azapentacyclo[10.5.2.0¹,¹³.0²,¹⁰.0⁴,⁸]nonadeca-2,4(8),9,16-tetraene-11,15-diol
C16H17NO4 (287.11575220000003)
(1s,11r,13r,15r)-5,7-dioxa-12-azapentacyclo[10.5.2.0¹,¹³.0²,¹⁰.0⁴,⁸]nonadeca-2,4(8),9,16-tetraene-11,15-diol
C16H17NO4 (287.11575220000003)
(1s,11s,13r,15r)-5,7-dioxa-12-azapentacyclo[10.5.2.0¹,¹³.0²,¹⁰.0⁴,⁸]nonadeca-2,4(8),9,16-tetraene-11,15-diol
C16H17NO4 (287.11575220000003)
(1s,13s,15r,18s)-5,7-dioxa-12-azapentacyclo[10.5.2.0¹,¹³.0²,¹⁰.0⁴,⁸]nonadeca-2,4(8),9,16-tetraene-15,18-diol
C16H17NO4 (287.11575220000003)
6-{[2-(3h-imidazol-4-yl)ethyl](methyl)amino}pteridine-2,4-diol
2-[4-(hydroxymethyl)-1,3-thiazol-2-yl]-4-methoxynaphthalen-1-ol
C15H13NO3S (287.06161080000004)
(2s)-4-({4-methoxyfuro[2,3-b]quinolin-7-yl}oxy)butan-2-ol
C16H17NO4 (287.11575220000003)
13-isopropyl-16-methyl-3,5,14-trioxa-16-azatetracyclo[7.7.0.0²,⁶.0¹¹,¹⁵]hexadeca-1,6,8,11(15)-tetraen-10-one
C16H17NO4 (287.11575220000003)
1-[3-(3,4-dimethoxyphenyl)prop-2-enoyl]-5,6-dihydropyridin-2-one
C16H17NO4 (287.11575220000003)
(2s)-2-{[(2s)-2-amino-1-hydroxypropylidene]amino}-3-hydroxy-3-[(3r,5s)-7-oxo-4-oxa-1-azabicyclo[3.2.0]heptan-3-yl]propanoic acid
(1s,13s,15s,18r)-5,7-dioxa-12-azapentacyclo[10.5.2.0¹,¹³.0²,¹⁰.0⁴,⁸]nonadeca-2,4(8),9,16-tetraene-15,18-diol
C16H17NO4 (287.11575220000003)
n-[(1s)-1-(4-methoxy-6-oxopyran-2-yl)-2-phenylethyl]ethanimidic acid
C16H17NO4 (287.11575220000003)
(1s,13r,15s,16s)-5,7-dioxa-12-azapentacyclo[10.6.1.0²,¹⁰.0⁴,⁸.0¹³,¹⁸]nonadeca-2,4(8),9,17-tetraene-15,16-diol
C16H17NO4 (287.11575220000003)
(1s,11r,13s,15r)-5,7-dioxa-12-azapentacyclo[10.5.2.0¹,¹³.0²,¹⁰.0⁴,⁸]nonadeca-2,4(8),9,16-tetraene-11,15-diol
C16H17NO4 (287.11575220000003)
(1s,13s,15s,18s)-5,7-dioxa-12-azapentacyclo[10.5.2.0¹,¹³.0²,¹⁰.0⁴,⁸]nonadeca-2,4(8),9,16-tetraene-15,18-diol
C16H17NO4 (287.11575220000003)
1-(2-hydroxy-4,8-dimethoxyquinolin-3-yl)-3-methylbut-3-en-2-one
C16H17NO4 (287.11575220000003)
5,7-dioxa-12-azapentacyclo[10.6.1.0²,¹⁰.0⁴,⁸.0¹³,¹⁸]nonadeca-2,4(8),9,17-tetraene-15,16-diol
C16H17NO4 (287.11575220000003)
2-hydroxy-6-({[2-(hydroxymethyl)phenyl]methyl}imino)-2,5-dimethylcyclohex-4-ene-1,3-dione
C16H17NO4 (287.11575220000003)
(1s,13r,15s,18s)-5,7-dioxa-12-azapentacyclo[10.5.2.0¹,¹³.0²,¹⁰.0⁴,⁸]nonadeca-2,4(8),9,16-tetraene-15,18-diol
C16H17NO4 (287.11575220000003)
(2s,3s)-2-{[(2s)-2-amino-1-hydroxypropylidene]amino}-3-hydroxy-3-[(3s,5s)-7-oxo-4-oxa-1-azabicyclo[3.2.0]heptan-3-yl]propanoic acid
7-amino-6,8,9-trihydroxy-4-methoxy-3-methylphenalen-1-one
3,4-dihydroxy-n-(1-hydroxy-3-phenylpropan-2-yl)benzenecarboximidic acid
C16H17NO4 (287.11575220000003)
(3r,6r)-3-(1-hydroxyethyl)-6-(1h-indol-3-ylmethyl)-3,6-dihydropyrazine-2,5-diol
C15H17N3O3 (287.12698520000004)
n-[(2r,3r,3ar,6r,6as)-2-hydroxy-6-[(3-methylbutanoyl)oxy]-hexahydrofuro[3,2-b]furan-3-yl]ethanimidic acid
C13H21NO6 (287.13688060000004)
(1s,4s)-4-hydroxy-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}cyclopent-2-ene-1-carbonitrile
14-methoxy-13-methyl-2-oxa-9-azatricyclo[9.4.0.0³,⁸]pentadeca-1(11),3,5,7,9,12,14-heptaene-5,10,12-triol
5,7-dioxa-12-azapentacyclo[10.5.2.0¹,¹³.0²,¹⁰.0⁴,⁸]nonadeca-2,4(8),9,16-tetraene-11,15-diol
C16H17NO4 (287.11575220000003)
(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl 1-methylpyrrole-2-carboxylate
(1s)-4-hydroxy-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}cyclopent-2-ene-1-carbonitrile
(1s,16r)-16-methoxy-5-oxa-10-azatetracyclo[8.7.0.0¹,¹³.0²,⁷]heptadeca-2(7),12,14-triene-4,9-dione
C16H17NO4 (287.11575220000003)
3,4,5-trihydroxy-6-(2-hydroxy-4-iminopyrimidin-1-yl)oxane-2-carboxylic acid
C10H13N3O7 (287.07534680000003)
(1s,13r,14s,15s)-6,8-dioxa-12-azapentacyclo[10.6.1.0²,¹⁰.0⁵,⁹.0¹³,¹⁸]nonadeca-2(10),3,5(9),17-tetraene-14,15-diol
C16H17NO4 (287.11575220000003)
(1s,11s,15r)-5,7-dioxa-12-azapentacyclo[10.5.2.0¹,¹³.0²,¹⁰.0⁴,⁸]nonadeca-2,4(8),9,16-tetraene-11,15-diol
C16H17NO4 (287.11575220000003)
5,7-dioxa-12-azapentacyclo[10.6.1.0²,¹⁰.0⁴,⁸.0¹³,¹⁸]nonadeca-2,4(8),9,17-tetraene-14,15-diol
C16H17NO4 (287.11575220000003)
n-[(3r,3ar,6r,6as)-2-hydroxy-6-[(3-methylbutanoyl)oxy]-hexahydrofuro[3,2-b]furan-3-yl]ethanimidic acid
C13H21NO6 (287.13688060000004)
2,5,7,13-tetraoxa-18-azahexacyclo[12.7.0.0³,¹¹.0⁴,⁸.0¹⁰,¹⁵.0¹⁵,¹⁹]henicosa-3,8,10-triene
C16H17NO4 (287.11575220000003)
(1r,13r,15s,18r)-5,7-dioxa-12-azapentacyclo[10.5.2.0¹,¹³.0²,¹⁰.0⁴,⁸]nonadeca-2,4(8),9,16-tetraene-15,18-diol
C16H17NO4 (287.11575220000003)
(1s,4r)-4-hydroxy-1-{[(2r,3s,4r,5r,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}cyclopent-2-ene-1-carbonitrile
5,7-dioxa-12-azapentacyclo[10.6.1.0²,¹⁰.0⁴,⁸.0¹³,¹⁸]nonadeca-2,4(8),9,16-tetraene-15,18-diol
C16H17NO4 (287.11575220000003)
3-[(2-{[ethoxy(hydroxy)methylidene]amino}ethoxy(hydroxy)phosphoryl)oxy]propane-1,2-diol
5,17-dimethyl-3,8-dioxa-10-azapentacyclo[10.8.0.0²,⁶.0⁷,¹¹.0¹³,¹⁸]icosa-1,4,6,9,11,13(18),14,16,19-nonaene
2,6-dihydroxy-n-[2-(4-methoxyphenyl)ethyl]benzenecarboximidic acid
C16H17NO4 (287.11575220000003)
(1s,13r,15r,18s)-5,7-dioxa-12-azapentacyclo[10.5.2.0¹,¹³.0²,¹⁰.0⁴,⁸]nonadeca-2,4(8),9,16-tetraene-15,18-diol
C16H17NO4 (287.11575220000003)
4-amino-7-[(2r,3r,4s)-3-hydroxy-4-methoxy-5-methylideneoxolan-2-yl]pyrrolo[2,3-d]pyrimidine-5-carbonitrile
(1r,4s)-4-hydroxy-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}cyclopent-2-ene-1-carbonitrile
3,4-dihydroxy-n-[(2s)-1-hydroxy-3-phenylpropan-2-yl]benzenecarboximidic acid
C16H17NO4 (287.11575220000003)
5,7-dioxa-12-azapentacyclo[10.5.2.0¹,¹³.0²,¹⁰.0⁴,⁸]nonadeca-2,4(8),9,14-tetraene-16,17-diol
C16H17NO4 (287.11575220000003)
(1s,13r,16s,17r)-5,7-dioxa-12-azapentacyclo[10.5.2.0¹,¹³.0²,¹⁰.0⁴,⁸]nonadeca-2,4(8),9,14-tetraene-16,17-diol
C16H17NO4 (287.11575220000003)
6-methoxy-7-(3-methylbut-2-en-1-yl)-2h-[1,3]dioxolo[4,5-h]quinolin-8-ol
C16H17NO4 (287.11575220000003)
5,17-dimethyl-3,10-dioxa-8-azapentacyclo[10.8.0.0²,⁶.0⁷,¹¹.0¹³,¹⁸]icosa-1,4,6,8,11,13(18),14,16,19-nonaene
(2e)-1-(3,4-dihydro-2h-pyridin-1-yl)-3-(7-methoxy-2h-1,3-benzodioxol-5-yl)prop-2-en-1-one
C16H17NO4 (287.11575220000003)
(2r)-2-hydroxy-6-({[2-(hydroxymethyl)phenyl]methyl}imino)-2,5-dimethylcyclohex-4-ene-1,3-dione
C16H17NO4 (287.11575220000003)
3,13,17-triazapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-1(21),2(10),4,6,8,15,17,19-octaen-14-one
n-[(3s,3ar,6r,6as)-2-hydroxy-6-[(3-methylbutanoyl)oxy]-hexahydrofuro[3,2-b]furan-3-yl]ethanimidic acid
C13H21NO6 (287.13688060000004)
(2r)-3-[(2-{[ethoxy(hydroxy)methylidene]amino}ethoxy(hydroxy)phosphoryl)oxy]propane-1,2-diol
16-methoxy-5-oxa-10-azatetracyclo[8.7.0.0¹,¹³.0²,⁷]heptadeca-2(7),12,14-triene-4,11-dione
C16H17NO4 (287.11575220000003)
(1r,4r)-4-hydroxy-1-{[(2s,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}cyclopent-2-ene-1-carbonitrile
1,5-dihydroxy-4-methoxy-3,10-dimethyl-8a,10a-dihydroacridin-9-one
C16H17NO4 (287.11575220000003)
(1r,11s,15r,18r,19s)-5,7,20,21-tetraoxa-14-azahexacyclo[16.2.1.0²,¹⁰.0⁴,⁸.0¹¹,¹⁵.0¹¹,¹⁹]henicosa-2(10),3,8-triene
C16H17NO4 (287.11575220000003)
(1s,7r,16r)-16-methoxy-5-oxa-10-azatetracyclo[8.7.0.0¹,¹³.0²,⁷]heptadeca-2,12,14-triene-4,9-dione
C16H17NO4 (287.11575220000003)
n-[(2r,3s,3ar,6r,6as)-2-hydroxy-6-[(3-methylbutanoyl)oxy]-hexahydrofuro[3,2-b]furan-3-yl]ethanimidic acid
C13H21NO6 (287.13688060000004)